In each instance, women years old with mild to moderate menopausal symptoms were randomized between two groups. Half of the women took two Amberen for 3-months, while the other half took a placebo. While prescription hormone therapy is the most effective approach for managing menopausal symptoms, Amberen might be considered as well as lifestyle modification, diet, and physical activity when prescription medications are declined or contraindicated due to other health issues.
The ingredients found in Amberen are also found in many other foods and nutritional supplements. Getting healthy amounts of these foods can provide numerous benefits and protect the body against symptoms of the aging process. Prolonged Release Melatonin Supplement Rated 3. Lack of sleep makes you more prone to stress, anxiety, and anger throughout the day.
A study by the National Institutes of Health NIH found sleeping less than seven hours per night increases the risk of obesity by 30 percent. At Cooper Complete we recommend the naturally-occurring hormone melatonin for sleeplessness. Natural melatonin levels decrease with age. Different from Amberen, we offer quick-release and prolonged release options to support those who struggle to fall asleep and those who fall asleep easily yet have difficulty staying asleep.
Quick Release Melatonin Supplement Rated 4. Menopausal women often experience increasing fatigue and decreasing metabolism. However, daily exercise can ease these symptoms.
Regular physical activity — as little as 30 minutes of exercise most days of the week, and a healthy diet provide many health improvements. Specifically, these two activities help improve mood, reduce stress, increase resistance to most diseases and improve overall health.
A five-week study in using Amberen involved both mice and a randomized control trial of 70 women. The mice showed improvements in skin, coat, and fertility. The human portion of the study showed sharp increases in blood serum estradiol and favorable improvements in standardized questionnaire scores.
A randomized controlled study in involving women demonstrated significant improvements in hormone levels, symptoms, anxiety. In addition, some women experienced decreases in waist circumference. A review pooled the information from two identical day studies, with a total of postmenopausal women in the treatment group. Significant improvements were reported in 15 menopausal symptoms during the study for subjects who took Amberen. I did notice that one of the researchers was disclosed as a paid staff member of Biogix, Inc, which owns the rights to Amberen.
At least four studies show that Amberen has good efficacy potential. Consumers should be aware that there may be conflicts of interest between the product and the researchers in charge of the studies. Several studies back the claims of the single ingredient ERr as a treatment for menopause symptoms. In , a study of menopausal women taking ERr for 6 months resulted in a significant and favorable reduction of standard questionnaire scores from Estroven also claims to work faster than other products, alleviating some symptoms in as little as 28 days.
In , a randomized, double-blind study of perimenopausal women used both the Hamilton Anxiety Scale and a standardized questionnaire, showing reduced symptoms within four weeks of treatment with ERr Research seems to show potential for the efficacy of Estroven.
These studies are larger in size than available Amberen studies. The studies document no adverse effects during their day course. However, because menopause symptoms last for years, longer-term safety needs to be established. The website claims the study involved women, showing that the ingredients were safe and effective.
However, the actual research study is not available for review, according to an Amberen representative. Inaccessible information makes me doubt the credibility of the study.
This product is contraindicated for women with some estrogen-dependent cancers and may not be safe for several other conditions. The above and studies reported no adverse effects for ERr ERr also had a long-term, 2-year study available for review. The study published in used the same women involved in a previously mentioned study. Hot flashes were reduced to an average of 1. No adverse effects were reported. A safety history paper was written in regarding adverse effects to date of Err When the paper was written, there had been only 5.
Statistically significant reduction in designated symptom severity, compared between arms. Secondary Outcome Measures : "Heart beating quickly and strongly" symptom Greene Climacteric Scale [ Time Frame: week 12 ] Statistically significant reduction in designated symptom severity, compared between arms.
Statistically significant reduction in the levels, compared between arms. Statistically significant reduction in the measurement, compared between arms. Eligibility Criteria. Inclusion Criteria: Female patients, years of age; Patient with diagnosis of "climacteric syndrome", in typical or non-complicated form, mild or moderate vegetative symptoms during menopause i.
Exclusion Criteria: Presence of female reproductive system cancers breast cancer, cervical cancer etc. Contacts and Locations. Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials. More Information. Succinate B complex vitamins menopause. National Library of Medicine U. National Institutes of Health U.
Department of Health and Human Services. The safety and scientific validity of this study is the responsibility of the study sponsor and investigators.
Climacteric Syndrome Menopause. Not Applicable. Study Type :. Interventional Clinical Trial.
0コメント